JP2008522630A5 - - Google Patents

Download PDF

Info

Publication number
JP2008522630A5
JP2008522630A5 JP2007545722A JP2007545722A JP2008522630A5 JP 2008522630 A5 JP2008522630 A5 JP 2008522630A5 JP 2007545722 A JP2007545722 A JP 2007545722A JP 2007545722 A JP2007545722 A JP 2007545722A JP 2008522630 A5 JP2008522630 A5 JP 2008522630A5
Authority
JP
Japan
Prior art keywords
cell line
recombinant adenovirus
deposited
name
accession number
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007545722A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008522630A (ja
JP4621743B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/045097 external-priority patent/WO2006065827A2/en
Publication of JP2008522630A publication Critical patent/JP2008522630A/ja
Publication of JP2008522630A5 publication Critical patent/JP2008522630A5/ja
Application granted granted Critical
Publication of JP4621743B2 publication Critical patent/JP4621743B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007545722A 2004-12-13 2005-12-12 複製欠損アデノウイルスの産生のための細胞株 Expired - Fee Related JP4621743B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63556104P 2004-12-13 2004-12-13
US67448805P 2005-04-25 2005-04-25
PCT/US2005/045097 WO2006065827A2 (en) 2004-12-13 2005-12-12 Cell lines for production of replication-defective adenovirus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010199416A Division JP2011015696A (ja) 2004-12-13 2010-09-06 複製欠損アデノウイルスの産生のための細胞株

Publications (3)

Publication Number Publication Date
JP2008522630A JP2008522630A (ja) 2008-07-03
JP2008522630A5 true JP2008522630A5 (https=) 2010-10-21
JP4621743B2 JP4621743B2 (ja) 2011-01-26

Family

ID=36282846

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007545722A Expired - Fee Related JP4621743B2 (ja) 2004-12-13 2005-12-12 複製欠損アデノウイルスの産生のための細胞株
JP2010199416A Withdrawn JP2011015696A (ja) 2004-12-13 2010-09-06 複製欠損アデノウイルスの産生のための細胞株

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010199416A Withdrawn JP2011015696A (ja) 2004-12-13 2010-09-06 複製欠損アデノウイルスの産生のための細胞株

Country Status (8)

Country Link
US (1) US7851218B2 (https=)
EP (1) EP1831352B1 (https=)
JP (2) JP4621743B2 (https=)
CN (1) CN101208425B (https=)
AT (1) ATE516343T1 (https=)
CA (1) CA2590943C (https=)
MX (1) MX2007007145A (https=)
WO (1) WO2006065827A2 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2487811A1 (en) 2002-05-27 2003-12-04 Per Sonne Holm Use of adenoviruses replicating in a yb-1 dependent manner for the treatment of tumors
EP1689445B1 (de) 2003-11-14 2015-02-25 Per Sonne Holm Neue verwendung von adenoviren und dafür codierende nukleinsäuren
CA2590943C (en) 2004-12-13 2013-10-22 Canji, Inc. Cell lines for production of replication-defective adenovirus
EP1830864A2 (de) * 2004-12-31 2007-09-12 Per Sonne Holm E1 -minus adenoviren und deren verwendung
DE602006019916D1 (de) * 2005-12-12 2011-03-10 Canji Inc Adenovirale expressionsvektoren mit einer expressionskassette im e1-bereich und einer inaktivierten e2b-polymerase
WO2011046757A2 (en) * 2009-10-12 2011-04-21 Rajabrata Sarkar Accelerating thrombus resolution through augmentation of p53 activity
WO2013052832A2 (en) 2011-10-05 2013-04-11 Genvec, Inc. Adenoviral vectors and methods of use
EP2764012B1 (en) * 2011-10-05 2022-02-23 GenVec, Inc. Adenoviral vectors and methods of use
US9629906B2 (en) 2011-10-05 2017-04-25 Genvec, Inc. Affenadenovirus (gorilla) or adenoviral vectors and methods of use
JP5969044B2 (ja) * 2011-11-24 2016-08-10 バイロメッド カンパニー リミテッド アデノウイルス生産新規細胞株及びその用途
EP2855511B1 (en) 2012-05-29 2019-07-24 GenVec, Inc. Herpes simplex virus vaccine
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
US10398761B2 (en) 2015-08-25 2019-09-03 Armo Biosciences, Inc. Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers
CN110832072B (zh) * 2017-04-21 2023-11-07 真基因太科公司 用于生产非复制型腺病毒的细胞系以及制备所述细胞系的方法
US20210155978A1 (en) * 2017-07-10 2021-05-27 Gen-Probe Incorporated Analytical systems and methods for nucleic acid amplification using sample assigning parameters
CA3120715A1 (en) * 2018-11-21 2020-05-28 Mayo Foundation For Medical Education And Research Adenoviruses and methods for using adenoviruses
CN114901828A (zh) * 2019-12-30 2022-08-12 南京金斯瑞生物科技有限公司 一种哺乳动物表达系统使用的高表达载体
CA3174985A1 (en) 2020-04-07 2021-10-14 Lung Biotechnology Pbc Adenoviral expression vector and methods and cell lines for production
CN113736780B (zh) * 2020-05-28 2024-05-28 暨南大学 一种敲除p300基因的BCBL1细胞系及其构建方法与应用
CN114262691A (zh) * 2020-09-16 2022-04-01 杭州康万达医药科技有限公司 分离的能够用于表达外源基因的溶瘤腺病毒、载体、治疗剂及其用途
CN112156181A (zh) * 2020-09-29 2021-01-01 广州恩宝生物医药科技有限公司 一种腺病毒四价疫苗
CN117264902A (zh) * 2022-06-15 2023-12-22 上海元宋生物技术有限公司 一种腺病毒包装与生产细胞系的构建方法及应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835557B1 (en) * 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
US6210939B1 (en) * 1993-10-25 2001-04-03 Canji, Inc. Recombinant adenoviral vector and methods of use
TW442569B (en) * 1993-10-25 2001-06-23 Canji Inc Recombinant adenoviral vector
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
SI0833934T2 (sl) * 1995-06-15 2013-04-30 Crucell Holland B.V. Pakirni sistemi za humani rekombinantni adenovirus za uporabo v genski terapiji
US5789244A (en) * 1996-01-08 1998-08-04 Canji, Inc. Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
US6392069B2 (en) * 1996-01-08 2002-05-21 Canji, Inc. Compositions for enhancing delivery of nucleic acids to cells
US5891690A (en) * 1996-04-26 1999-04-06 Massie; Bernard Adenovirus E1-complementing cell lines
US6248514B1 (en) * 1996-07-09 2001-06-19 Canji, Inc. Methods for measuring viral infectivity
US6261823B1 (en) * 1996-12-13 2001-07-17 Schering Corporation Methods for purifying viruses
US6544769B1 (en) * 1996-12-13 2003-04-08 Schering Corporation Compostions comprising viruses and methods for concentrating virus preparations
US6146891A (en) * 1997-01-31 2000-11-14 Schering Corporation Methods for cultivating cells and propagating viruses
KR100912362B1 (ko) 1998-02-17 2009-08-19 쉐링 코포레이션 바이러스 제제의 정제방법
US6670188B1 (en) * 1998-04-24 2003-12-30 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US5994134A (en) * 1998-05-04 1999-11-30 Canji, Inc. Viral production process
US6649158B1 (en) * 1998-10-15 2003-11-18 Canji, Inc. Methods and compositions to induce antitumor response
US7001770B1 (en) * 1998-10-15 2006-02-21 Canji, Inc. Calpain inhibitors and their applications
US7691370B2 (en) * 1998-10-15 2010-04-06 Canji, Inc. Selectivity replicating viral vector
US6430595B1 (en) * 1999-05-20 2002-08-06 Cisco Technology, Inc. Method and apparatus for establishing a database used for correlating information gathered via SNMP
US20020064860A1 (en) * 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
JP2007526219A (ja) 2003-06-04 2007-09-13 カンジ，インコーポレイテッド トランスフェクション薬剤
US7026164B2 (en) * 2003-07-03 2006-04-11 Cell Genesys, Inc. Adenovirus packaging cell lines
CA2548100C (en) 2003-12-10 2015-03-24 Canji, Inc. Methods and compositions for treatment of interferon-resistant tumors
CA2590943C (en) 2004-12-13 2013-10-22 Canji, Inc. Cell lines for production of replication-defective adenovirus
KR20080100250A (ko) 2006-02-10 2008-11-14 프라이 유니베르시탯 베를린 생물학적 시료 준비 방법 및 장치

Similar Documents

Publication Publication Date Title
JP2008522630A5 (https=)
JP2020022459A5 (https=)
NZ595305A (en) Methods and reagents for treatment and diagnosis of age-related macular degeneration
JP2010531148A5 (https=)
JP2010273685A5 (https=)
JP2006115849A5 (https=)
JP2008245635A5 (https=)
AU2014203512B2 (en) Recombinant virus-like particles encoded by multi-gene vector
WO2009116861A3 (en) Diagnostic of pre-symptomatic metabolic syndrome
KR102160486B1 (ko) 돼지생식기호흡기증후군(prrs) 바이러스 유전형 판별용 pna 프로브 및 이를 이용한 돼지생식기호흡기증후군(prrs) 유전형 판별방법
JP2012531205A5 (https=)
JP2011500592A5 (https=)
JP2007075118A5 (https=)
MY163972A (en) Attenuated recombinant newcastle disease virus and vaccine containing the same
JP2005523709A5 (https=)
JP2009523007A5 (https=)
WO2013030176A3 (en) Live attenuated influenza virus
EP2383343A3 (en) Recombinant varicella-zoster virus
DK1883695T3 (da) Probiotisk bifidobakterieart
IL179911A0 (en) Methods related to a single nucleotide polymorphism of the g protein coupled receptor, gpr40
JP2006507816A5 (https=)
CN111484994A (zh) CRISPR-Cas9特异性敲除猪Fah、Rag2双基因的方法
EP2434018A3 (en) A novel beta-galactoside-alpha2, 3-sialyltransferase, a gene encoding thereof, and a method for producing thereof
CA2624544A1 (en) Vero cell line adapted to grow in suspension
JP2007513601A5 (https=)